ATE503761T1 - Von aminosäuren abgeleitete, zyklische phosphonamide und verfahren zu deren synthese - Google Patents

Von aminosäuren abgeleitete, zyklische phosphonamide und verfahren zu deren synthese

Info

Publication number
ATE503761T1
ATE503761T1 AT07008428T AT07008428T ATE503761T1 AT E503761 T1 ATE503761 T1 AT E503761T1 AT 07008428 T AT07008428 T AT 07008428T AT 07008428 T AT07008428 T AT 07008428T AT E503761 T1 ATE503761 T1 AT E503761T1
Authority
AT
Austria
Prior art keywords
phosphonamide
ring
template
synthesis
derived
Prior art date
Application number
AT07008428T
Other languages
English (en)
Inventor
Paul R Hanson
Kevin T Sprott
Matthew D Mcreynolds
Original Assignee
Univ Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas filed Critical Univ Kansas
Application granted granted Critical
Publication of ATE503761T1 publication Critical patent/ATE503761T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2454Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2462Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of unsaturated acyclic amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/26Amides of acids of phosphorus containing P-halide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65848Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT07008428T 2000-08-15 2001-08-06 Von aminosäuren abgeleitete, zyklische phosphonamide und verfahren zu deren synthese ATE503761T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/639,051 US6420586B1 (en) 2000-08-15 2000-08-15 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same

Publications (1)

Publication Number Publication Date
ATE503761T1 true ATE503761T1 (de) 2011-04-15

Family

ID=24562532

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07008428T ATE503761T1 (de) 2000-08-15 2001-08-06 Von aminosäuren abgeleitete, zyklische phosphonamide und verfahren zu deren synthese
AT01964579T ATE463500T1 (de) 2000-08-15 2001-08-06 Von aminosäuren abgeleitete zyklische phosphonamide und verfahren zu deren herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT01964579T ATE463500T1 (de) 2000-08-15 2001-08-06 Von aminosäuren abgeleitete zyklische phosphonamide und verfahren zu deren herstellung

Country Status (9)

Country Link
US (1) US6420586B1 (de)
EP (2) EP1806351B1 (de)
JP (1) JP5249486B2 (de)
AT (2) ATE503761T1 (de)
AU (1) AU2001285418A1 (de)
CA (1) CA2419775C (de)
DE (2) DE60144349D1 (de)
DK (2) DK1806351T3 (de)
WO (1) WO2002014344A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030018053A (ko) * 2000-07-18 2003-03-04 레오 파마 에이/에스 매트릭스 메탈로프로티나제 억제제
CN1714096A (zh) * 2002-01-18 2005-12-28 利奥制药有限公司 Mmp抑制剂
MXPA04010527A (es) * 2002-04-26 2004-12-13 Gilead Sciences Inc Acumulacion celular de analogos de fosfonato de los compuestos inhibidores de la proteasa del virus de inmunodeficiencia humana (vih).
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
WO2004096285A2 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Anti-infective phosphonate conjugates
US7417055B2 (en) 2003-04-25 2008-08-26 Gilead Sciences, Inc. Kinase inhibitory phosphonate analogs
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US7427636B2 (en) 2003-04-25 2008-09-23 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
EP1628685B1 (de) 2003-04-25 2010-12-08 Gilead Sciences, Inc. Antivirale phosphonate analoge
US7427624B2 (en) 2003-10-24 2008-09-23 Gilead Sciences, Inc. Purine nucleoside phosphorylase inhibitory phosphonate compounds
CA2543144A1 (en) 2003-10-24 2005-05-12 Gilead Sciences, Inc. Methods and compositions for identifying therapeutic compounds
US7432273B2 (en) 2003-10-24 2008-10-07 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
US20080287471A1 (en) 2003-12-22 2008-11-20 Maria Fardis 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
PL216369B1 (pl) 2004-07-27 2014-03-31 Gilead Sciences Pochodne fosfonianowe, kompozycje farmaceutyczne zawierające te pochodne oraz zastosowanie tych pochodnych do wytwarzania leku do hamowania wirusa HIV
US8592336B2 (en) 2006-04-11 2013-11-26 Agency For Science, Technology And Research Catalysts for ring-closing metathesis
US8648003B2 (en) 2006-04-11 2014-02-11 Agency For Science, Technology And Research Catalysts for ring-closing metathesis
PE20110219A1 (es) 2008-07-08 2011-03-31 Gilead Sciences Inc Sales del compuesto n-[(s)({[(2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il]oxi}metil)fenoxifosfinoil]-l-alaninato de etilo como inhibidores de vih
JP2013023454A (ja) * 2011-07-19 2013-02-04 Katayama Kagaku Kogyo Kk ハロゲン化有機リン化合物の製造方法
EP3960740B1 (de) 2017-08-01 2023-11-15 Gilead Sciences, Inc. Kristalline formen von ethyl((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluor-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninat (gs-9131) vanillate zur behandlung von virusinfektionen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3329687A (en) 1964-01-16 1967-07-04 Sandoz Ag Thiadiazepinedioxides and their preparation
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5710298A (en) 1992-04-03 1998-01-20 California Institute Of Technology Method of preparing ruthenium and osmium carbene complexes
US5312940A (en) 1992-04-03 1994-05-17 California Institute Of Technology Ruthenium and osmium metal carbene complexes for olefin metathesis polymerization
EP1251135A3 (de) 1992-04-03 2004-01-02 California Institute Of Technology Hochwirksame Ruthenium- und Osmium- Metall-Carbenkomplexe für die Olefinmetathesereaktionen, und deren Herstellung
AU703962B2 (en) * 1993-02-26 1999-04-01 Du Pont Pharmaceuticals Company Substituted cyclic carbonyls and derivatives
US5543517A (en) * 1994-01-13 1996-08-06 The Dupont Merck Pharmaceutical Company Substituted bicyclic phosphoramides and derivatives thereof
US6083711A (en) 1996-05-15 2000-07-04 Smithkline Beecham Corporation Proteases compositions capable of binding to said site, and methods of use thereof
US5917071A (en) 1996-11-15 1999-06-29 California Institute Of Technology Synthesis of ruthenium or osmium metathesis catalysts
WO1999037643A1 (fr) 1998-01-26 1999-07-29 Yamanouchi Pharmaceutical Co., Ltd. Nouveaux derives heterocycliques a fusion benzenique ou sels de ceux-ci

Also Published As

Publication number Publication date
EP1311515B1 (de) 2010-04-07
WO2002014344A3 (en) 2002-09-06
JP5249486B2 (ja) 2013-07-31
CA2419775A1 (en) 2002-02-21
DE60141757D1 (de) 2010-05-20
JP2004506646A (ja) 2004-03-04
DE60144349D1 (de) 2011-05-12
DK1806351T3 (da) 2011-07-18
EP1806351A3 (de) 2007-09-26
ATE463500T1 (de) 2010-04-15
US6420586B1 (en) 2002-07-16
EP1806351B1 (de) 2011-03-30
EP1806351A2 (de) 2007-07-11
EP1311515A2 (de) 2003-05-21
EP1311515A4 (de) 2003-12-03
AU2001285418A1 (en) 2002-02-25
CA2419775C (en) 2014-12-02
DK1311515T3 (da) 2010-07-19
WO2002014344A2 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
ATE503761T1 (de) Von aminosäuren abgeleitete, zyklische phosphonamide und verfahren zu deren synthese
DE69937223D1 (de) Verfahren zur synthese von nukleinsäuren
DE69900462D1 (de) Konjugate von dns und pns und verfahren zu deren herstellung
NO973335D0 (no) Fremgangsmåte for fremstilling av et flertall kjemiske stoffer i en tabelloppstilling
DE69637726D1 (de) Gruppen zum einfangen von nukleinsäuren
MY136437A (en) Methods and apparatus for nucleic acid sequencing by signal stretching and data intergration
DE69809685D1 (de) Verfahren zur Herstellung von Olefinen durch direkte Umsetzung mehrerer Kohlenwasserstoffe
ATE191748T1 (de) Verfahren zum nachweis ähnlicher nukleinsäuren
DE69829722D1 (de) Verfahren zur Herstellung von Katalysatoren zur Verwendung in Umwandlungsreaktionen von organischen Verbindungen
ID17243A (id) Metode pembuatan komplek obat
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
DE69833200D1 (de) Verfahren für die produktion von l-glutaminsäure mittels fermentation
DE69938067D1 (de) Verfahren zur Entfernung von organischen Verbindungen mittels Verbrennungskatalysatoren
DE50005649D1 (de) Verfahren zur Herstellung von Alkylphosphonsäuren
DE69116668T2 (de) Verfahren zur Umsetzung von Aminogruppen enthaltenden organischen Siliciumverbindungen zu Acrylamidgruppen enthaltenden Verbindungen
DE3867927D1 (de) Guanidin-verbindungen, die ein substituiertes tetraphenylboration enthalten, verfahren zu deren herstellung und verwendung dieser verbindungen waehrend der peptid-synthese.
ATE159521T1 (de) Thioacylierungsmittel und zwischenprodukte, thiopeptide, und verfahren zu deren herstellung und anwendung
ATE253030T1 (de) Verfahren zur herstellung von 1,1,4,4- tetramethoxybuten-2
CA2180292A1 (en) Recovery of reactants and products in production of alkenyl bridged ring compounds
ATE236875T1 (de) Verfahren zur herstellung von cyclischen lactamen
ATE305521T1 (de) Verfahren zur bindung von nukleinsäuren an einen träger
DE60032759D1 (de) Funktionalisierte festträger zur herstellung von alpha-oxoaldehyden
ATE375995T1 (de) Verfahren zur synthese von peptiden, die mindestens ein glycinmolekül enthalten
DE60327765D1 (de) Verfahren zur herstellung von n-(2,6-dimethylphenyl)-2-piperazin-1-ylacetamid
DE59603757D1 (de) Verfahren zur Herstellung von kristallinem O-Isopropylisoharnstoff-hydrochlorid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties